Author(s):
Gaikwad Harsh Ravikant, Dhangar Swapnil Pravin, Amol. R. Pawar
Email(s):
hgaikwad472@gmail.com
DOI:
10.52711/0974-4150.2025.00028 
Address:
Gaikwad Harsh Ravikant*, Dhangar Swapnil Pravin, Amol. R. Pawar
Institute of Pharmaceutical Education, Boradi, K.B.C University, Jalgaon 425428 Maharashtra, India.
*Corresponding Author
Published In:
Volume - 18,
Issue - 3,
Year - 2025
ABSTRACT:
The aim of this study is to develop a syrup for the treatment of chronic obstructive pulmonary disease (COPD), which is caused by smoking, atmospheric pollution, and infections. This study seeks to create an oral treatment for COPD patients that alleviates chronic cough and aids in breathing. The syrup is formulated using natural ingredients, with the key components being Adhatoda vasica, Verbascum thapsus, Piper Nigrum Linn, Zingiber officinale, Linum usitatissimum, and Curcuma longa.
Cite this article:
Gaikwad Harsh Ravikant, Dhangar Swapnil Pravin, Amol. R. Pawar. Review on Natural Remedies for COPD: Development of Synergistic Herbal Syrup. Asian Journal of Research in Chemistry.2025; 18(3):174-8. doi: 10.52711/0974-4150.2025.00028
Cite(Electronic):
Gaikwad Harsh Ravikant, Dhangar Swapnil Pravin, Amol. R. Pawar. Review on Natural Remedies for COPD: Development of Synergistic Herbal Syrup. Asian Journal of Research in Chemistry.2025; 18(3):174-8. doi: 10.52711/0974-4150.2025.00028 Available on: https://www.ajrconline.org/AbstractView.aspx?PID=2025-18-3-10
REFERENCE:
1. Ansari, J., and Kaur, D. Medical Surgical Nursing-II (pp. 343–347). Pee Vee Publications.
2. Herbal Creations. Vasaka extract supplier manufacturers. Retrieved from https://herbal-creations.com/vasaka-extract-supplier-manufacturers/
3. Kaur, D., and Ansari, J. 2012. Constituents of Vasaka. Tandfonline. Retrieved from https://www.tandfonline.com/doi/pdf/10.1080/0972060X.2012.10644063
4. PubMed. 2005. Study on the pharmacological properties of Vasaka. Retrieved from https://pubmed.ncbi.nlm.nih.gov/16222647/
5. Healthline. 2021. Mullein leaf: Uses and benefits. Retrieved from https://www.healthline.com/health/mullein-leaf#uses
6. Citeseer X. Piper nigrum and its medicinal properties. Retrieved from https://citeseerx.ist.psu.edu/document?repid=rep1andtype=pdfanddoi=2591a2f79554f34649102cc22201e99f975b5581
7. Patel, S. Chemistry and Pharmacology of Piper nigrum L. ResearchGate. Retrieved from https://www.researchgate.net/profile/Samir-Patel-18/publication/257299404_Chemistry_and_pharmacology_of_Piper_Nigrum_L/links/0deec524cf2e929ca6000000/Chemistry-and-pharmacology-of-Piper-Nigrum-L.pdf
8. National Center for Biotechnology Information (NCBI). (2019). Study on the medicinal properties of Piper Nigrum. PMC. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6616534/
9. National Center for Biotechnology Information (NCBI). (2019). Continued pharmacological evaluation of Piper Nigrum. PMC. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6616534/
10. Tandfonline. (2014). Pharmacological uses of various medicinal plants. Retrieved from https://www.tandfonline.com/doi/full/10.3109/13880209.2014.920396
11. Gogte, V. M. Ayurvedic Pharmacology and Therapeutic Uses of Medicinal Plants (Dravyagunavignyan). Bharatiya Vidya Bhavan.
12. Akram, M. Curcuma longa and Curcumin: A review article. ResearchGate. Retrieved from https://www.researchgate.net/profile/Muhammad-Akram-88/publication/284415430_Curcuma_longa_and_Curcumin_A_review_article/links/56e326b108ae65dd4cbac278/Curcuma-longa-and-Curcumin-A-review-article.pdf
13. NCBI Books. Curcumin: A promising agent for various therapeutic applications. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK92752/
14. Tandfonline. (2006). Therapeutic effects of turmeric. Retrieved from https://www.tandfonline.com/doi/full/10.2147/copd.2006.1.1.3#d1e86
15. European Respiratory Journal (ERJ). (2013). Role of turmeric in inflammatory diseases. Retrieved from https://erj.ersjournals.com/content/30/5/993.short
16. Patil, P. G., and Jadhav V. M. Formulation and evaluation of dry powder suspension using herbal seed extract. International Journal of Pharmaceutical Sciences and Research (IJPSR). 2023; 14(7): 3487-3491.
17. Brashier, B. B., and Kodgule, R. 2016. Risk factors and pathophysiology of chronic obstructive pulmonary disease (COPD). Retrieved from https://d1wqtxts1xzle7.cloudfront.net/49565507/Risk_factors_and_Pathophysiology_of_Chro20161013-6389-1b6e76x-libre.pdf
18. Gangwar, A. K., and Ghosh, A. K. Medicinal uses and pharmacological activity of Adhatoda vasica. Flora Journal. 2014; 2(1): Retrieved from https://www.florajournal.com/vol2issue1/april2014/23.1.pdf
19. Mohan, H. (2006). Textbook of Pathology (6th ed., pp. 477-480).
20. Soleimani, V., Sahebkar, A. H., and Hosseinzade, H. Turmeric (Curcuma longa) and its major constituents (Curcumin) as nontoxic and safe substances. Phytotherapy Research. 2018; 32(6): 985-995.
21. Nile, S. H. R., and Park, S. W. Chromatographic analysis, antioxidant, anti-inflammatory, and xanthine oxidase inhibitory activities of ginger extract and its reference compounds. Industrial Crops and Products. 2015; 70: 238-244